ABVX
Price
$65.37
Change
+$55.37 (+553.70%)
Updated
Jul 23, 02:14 PM (EDT)
Capitalization
665.08M
19 days until earnings call
DYN
Price
$9.41
Change
+$0.20 (+2.17%)
Updated
Jul 23, 02:47 PM (EDT)
Capitalization
1.3B
8 days until earnings call
Interact to see
Advertisement

ABVX vs DYN

Header iconABVX vs DYN Comparison
Open Charts ABVX vs DYNBanner chart's image
Abivax SA
Price$65.37
Change+$55.37 (+553.70%)
Volume$2.1K
Capitalization665.08M
Dyne Therapeutics
Price$9.41
Change+$0.20 (+2.17%)
Volume$100
Capitalization1.3B
ABVX vs DYN Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. DYN commentary
Jul 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Buy and DYN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 23, 2025
Stock price -- (ABVX: $10.14 vs. DYN: $9.17)
Brand notoriety: ABVX and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 340% vs. DYN: 58%
Market capitalization -- ABVX: $665.08M vs. DYN: $1.3B
ABVX [@Biotechnology] is valued at $665.08M. DYN’s [@Biotechnology] market capitalization is $1.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $284.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 1 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABVX and DYN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 6 TA indicator(s) are bullish while DYN’s TA Score has 5 bullish TA indicator(s).

  • ABVX’s TA Score: 6 bullish, 4 bearish.
  • DYN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ABVX is a better buy in the short-term than DYN.

Price Growth

ABVX (@Biotechnology) experienced а +14.84% price change this week, while DYN (@Biotechnology) price change was +2.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.08%. For the same industry, the average monthly price growth was +21.29%, and the average quarterly price growth was +31.06%.

Reported Earning Dates

ABVX is expected to report earnings on Aug 11, 2025.

DYN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+7.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.3B) has a higher market cap than ABVX($665M). ABVX YTD gains are higher at: 38.525 vs. DYN (-61.078). ABVX has higher annual earnings (EBITDA): -170.04M vs. DYN (-395.31M). DYN has more cash in the bank: 677M vs. ABVX (104M). DYN has less debt than ABVX: DYN (23.3M) vs ABVX (92.6M). ABVX (0) and DYN (0) have equivalent revenues.
ABVXDYNABVX / DYN
Capitalization665M1.3B51%
EBITDA-170.04M-395.31M43%
Gain YTD38.525-61.078-63%
P/E RatioN/AN/A-
Revenue00-
Total Cash104M677M15%
Total Debt92.6M23.3M397%
TECHNICAL ANALYSIS
Technical Analysis
ABVXDYN
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BNIEX11.620.07
+0.61%
UBS International Sustainable Equity A
HFCGX31.870.08
+0.25%
Hennessy Cornerstone Growth Investor
LHCIX18.22-0.06
-0.33%
Lord Abbett Health Care I
FIMVX28.49-0.16
-0.56%
Fidelity Mid Cap Value Index
JGMIX25.07-0.17
-0.67%
Janus Henderson Triton S

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with SYRE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+1.91%
SYRE - ABVX
40%
Loosely correlated
+0.37%
MLTX - ABVX
39%
Loosely correlated
+0.90%
CGON - ABVX
38%
Loosely correlated
+0.56%
XENE - ABVX
38%
Loosely correlated
-0.32%
DYN - ABVX
37%
Loosely correlated
+1.66%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+1.66%
RNA - DYN
57%
Loosely correlated
+0.77%
CRNX - DYN
56%
Loosely correlated
-0.51%
SYRE - DYN
54%
Loosely correlated
+0.37%
XNCR - DYN
54%
Loosely correlated
+1.45%
IDYA - DYN
52%
Loosely correlated
+1.02%
More